Table 4.
Vitreous mass (pg) of cytokines in the three groups.
| Control group | HM | mCNV | P* | P† | P‡ | |
|---|---|---|---|---|---|---|
| VEGF | 160.69 ± 88.54 | 197.12 ± 125.40 | 286.65 ± 126.91 | 0.764 | <0.001 | 0.014 |
| IL-6 | 34.68 ± 36.13 | 205.57 ± 209.42 | 106.13 ± 151.11 | <0.001 | 0.001 | 0.078 |
| IL-8 | 49.79 ± 35.99 | 93.81 ± 115.32 | 165.99 ± 118.54 | 0.014 | <0.001 | 0.013 |
| IL-10 | 3.52 ± 1.25 | 7.84 ± 2.02 | 7.9 ± 1.91 | <0.001 | <0.001 | 1 |
| IP-10 | 1031.34 ± 882.17 | 2235.28 ± 998.72 | 5399.93 ± 5278.21 | <0.001 | <0.001 | 0.017 |
| MCP-1 | 2024.6 ± 964.49 | 5326.76 ± 1582.40 | 6650.08 ± 4539.49 | <0.001 | <0.001 | 1 |
HM, High myopia without choroidal neovascularization group; mCNV, myopic choroidal neovascularization group; VEGF, vascular endothelial growth factor; IL-6, interleukin 6; IL-8, interleukin 8; IL-10, interleukin 10; IP-10, interferon-inducible protein 10; MCP-1, monocyte chemotactic protein 1. P*:control vs. HM, P†:control vs. mCNV, P‡:HM vs. mCNV. Bold values to highlight significant difference (P < 0.05).